Givinostat will be made available to eligible patients with Duchenne muscular dystrophy after its manufacturer struck a commercial deal with NHS England Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email Email * SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice Hundreds of children across England are set to benefit from a new